![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » YENKEY DRUGS MEMBERS TO APPROVE PREFERENTIAL ISSUE OF SECURITIES
YENKEY DRUGS MEMBERS TO APPROVE PREFERENTIAL ISSUE OF SECURITIES
August 29, 2005
Yenkey Drugs & Pharmaceuticals Ltd has increased authorized share capital of the company from Rs 5 crore divided into 50 lakh equity shares of Rs 10 each, to Rs 6 crore divided into 60 lakh equity shares of Rs 10 each, ranking pari passu with the existing equity shares and consequential amendment in memorandum and articles of association of the company. The board issues and allots 2,30,000 equity shares of Rs 10 each to the promoters or promoters group of the company and 6,96,000 equity shares of Rs 10- each to the persons other than promoters on preferential basis.
Myiris.com (http://www.myiris.com/newsCentre/newsPopup.php?fileR=20050829164951002&dir=2005/08/29&secID=livenews)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct